Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Stoltz, J F ^a,b   De Isla, N ^a   Li, Y P ^c   Bensoussan, D ^a   Zhang, L ^d   Huselstein, C ^a   Chen, Y ^e   Decot, V ^a   Magdalou, J ^a   Li, N ^f   Reppel, L ^a   He, Y ^c  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^d Service de Thérapie Cellulaire Calmette Hospital   (China)

^e WUHAN UNIVERSITY   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE DERIVED STEM CELL; ATHEROSCLEROSIS; BONE DISEASE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BRAIN ISCHEMIA; CANCER STEM CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CHONDROPATHY; DEGENERATIVE DISEASE; DIABETES MELLITUS; EMBRYONIC STEM CELL; ERECTILE DYSFUNCTION; EYE DISEASE; FETAL STEM CELL; HEART FAILURE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; MEDICAL ETHICS; MULTIPOTENT STEM CELL; NEUROLOGIC DISEASE; NONHUMAN; PANCREAS DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RETINA DISEASE; REVIEW; SKIN DISEASE; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT INDICATION; URINARY TRACT DISEASE; WHARTON JELLY;

EID: 84939477054     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/734731     Document Type: Review

References (264)

1. A. Islam, "Haemopoietic stem cell: A new concept, " Leukemia Research, vol. 9, no. 11, pp. 1415-1432, 1985.
2. M. Tavassoli and A. Friedenstein, "Hemopoietic stromal microenvironment, " The American Journal of Hematology, vol. 15, no. 2, pp. 195-203, 1983.
3. E. D. Thomas, H. L. Lochte Jr., J. H. Cannon, O. D. Sahler, and J. W. Ferrebee, "Supralethal whole body irradiation and isologous marrow transplantation in man, " The Journal of Clinical Investigation, vol. 38, pp. 1709-1716, 1959.
4. R. A. Gatti, H. J. Meuwissen, H. D. Allen, R. Hong, and R. A. Good, "Immunological reconstitution of sex-linked lymphopenic immunological deficiency, " The Lancet, vol. 2, no. 7583, pp. 1366-1369, 1968.
5. E. D. Thomas, "A history of haemopoietic cell transplantation, " British Journal ofHaematology, vol. 105, no. 2, pp. 330-339, 1999.
6. M. J. Evans and M. H. Kaufman, "Establishment in culture of pluripotential cells from mouse embryos, " Nature, vol. 292, no. 5819, pp. 154-156, 1981.
7. G. R. Martin, "Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 12, pp. 7634-7638, 1981.
8. K. Takahashi and S. Yamanaka, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, " Cell, vol. 126, no. 4, pp. 663-676, 2006.
9. K. Takahashi, K. Tanabe, M. Ohnuki et al., "Induction of pluripotent stem cells from adult human fibroblasts by defined factors, " Cell, vol. 131, no. 5, pp. 861-872, 2007.
10. E. Galende, I. Karakikes, L. Edelmann et al., "Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells, " Cellular Reprogramming, vol. 12, no. 2, pp. 117-125, 2010.
11. C. Magnon, D. Lucas, and P. Frenette, "Trafficking of stem cells, " in Stem Cell Migration: Methods and Protocols, vol. 750 of Methods in Molecular Biology, pp. 3-24, Humana Press, New York, NY, USA, 2011.
12. T. Zhao, Z.-N. Zhang, Z. Rong, and Y. Xu, "Immunogenicity of induced pluripotent stem cells, " Nature, vol. 474, no. 7350, pp. 212-215, 2011.
13. C. Campagnoli, I. A. G. Roberts, S. Kumar, P. R. Bennett, I. Bellantuono, and N. M. Fisk, "Identification of mesenchymal stem/progenitor cells in human first-Trimester fetal blood, liver, and bone marrow, " Blood, vol. 98, no. 8, pp. 2396-2402, 2001.
14. V. Dexheimer, S. Mueller, F. Braatz, and W. Richter, "Reduced reactivation from dormancy but maintained lineage choice of humanmesenchymal stemcellswith donor age, " PLoSONE, vol. 6, no. 8, Article ID e22980, 2011.
15. Y. Fukuchi, H. Nakajima, D. Sugiyama, I. Hirose, T. Kitamura, and K. Tsuji, "Human placenta-derived cells havemesenchymal stem/progenitor cell potential, " Stem Cells, vol. 22, no. 5, pp. 649-658, 2004.
16. C. A. Roufosse, N. C. Direkze, W. R. Otto, and N. A. Wright, "Circulating mesenchymal stem cells, " International Journal of Biochemistry and Cell Biology, vol. 36, no. 4, pp. 585-597, 2004.
17. D. Suva, G. Garavaglia, J. Menetrey et al., "Non-hematopoietic human bonemarrow contains long-lasting, pluripotentialmesenchymal stem cells, " Journal of Cellular Physiology, vol. 198, no. 1, pp. 110-118, 2004.
18. W. Wagner, F. Wein, A. Seckinger et al., "Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood, " Experimental Hematology, vol. 33, no. 11, pp. 1402-1416, 2005.
19. H.-S. Wang, S.-C. Hung, S.-T. Peng et al., "Mesenchymal stem cells in the Whartons jelly of the human umbilical cord, " Stem Cells, vol. 22, no. 7, pp. 1330-1337, 2004.
20. B. L. Yen, H.-I. Huang, C.-C. Chien et al., "Isolation of multipotent cells from human term placenta, " Stem Cells, vol. 23, no. 1, pp. 3-9, 2005.
21. G. Yu, X. Wu, M. A. Dietrich et al., "Yield and characterization of subcutaneous human adipose-derived stem cells by flow cytometric and adipogenic mRNA analyzes, " Cytotherapy, vol. 12, no. 4, pp. 538-546, 2010.
22. B. M. Abdallah and M. Kassem, "Human mesenchymal stem cells: from basic biology to clinical applications, " GeneTherapy, vol. 15, no. 2, pp. 109-116, 2008.
23. S. Aggarwal and M. F. Pittenger, "Human mesenchymal stem cells modulate allogeneic immune cell responses, " Blood, vol. 105, no. 4, pp. 1815-1822, 2005.
24. N. A. Kia, A. R. Bahrami, M. Ebrahimi et al., "Comparative analysis of chemokine receptors expression in mesenchymal stem cells derived from human bone marrow and adipose tissue, " Journal ofMolecular Neuroscience, vol. 44, no. 3, pp. 178-185, 2011.
25. A. Can and S. Karahuseyinoglu, "Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells, " Stem Cells, vol. 25, no. 11, pp. 2886-2895, 2007.
26. M. Dominici, K. Le Blanc, I. Mueller et al., "Minimal criteria for defining multipotent mesenchymal stromal cells: The international society for cellular therapy position statement, " Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006.
27. J. A. Efe, S. Hilcove, J. Kim et al., "Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy, " Nature Cell Biology, vol. 13, no. 3, pp. 215-222, 2011.
28. A. Mojallal, C. Lequeux, C. Shipkov et al., "Influence of age and body mass index on the yield and proliferation capacity of Adipose-derived stemcells, " Aesthetic Plastic Surgery, vol. 35, no. 6, pp. 1097-1105, 2011.
29. L. V. Rodríguez, Z. Alfonso, R. Zhang, J. Leung, B. Wu, and L. J. Ignarro, "Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smoothmuscle cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 32, pp. 12167-12172, 2006.
30. R. Sarugaser, D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies, "Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors, " Stem Cells, vol. 23, no. 2, pp. 220-229, 2005.
31. J.-W. Yang, N. de Isla, C. Huselstein et al., "Evaluation of human MSCs cell cycle, viability and differentiation in micromass culture, " Biorheology, vol. 43, no. 3-4, pp. 489-496, 2006.
32. M. Malinowski, K. Pietraszek, C. Perreau et al., "Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase, " PLoS ONE, vol. 7, no. 12, Article IDe50709, 2012.
33. J. Oswald, S. Boxberger, B. Jørgensen et al., "Mesenchymal stem cells can be differentiated into endothelial cells in vitro, " Stem Cells, vol. 22, no. 3, pp. 377-384, 2004.
34. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells, " Science, vol. 284, no. 5411, pp. 143-147, 1999.
35. V. Planat-Benard, J.-S. Silvestre, B. Cousin et al., "Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives, " Circulation, vol. 109, no. 5, pp. 656-663, 2004.
36. N. Salmon, E. Paternotte, V. Decot, J.-F. Stoltz, P. Menu, and P. Labrude, "Polyelectrolyte multilayer films promote human cord blood stem cells differentiation into mature endothelial cells exhibiting a stable phenotype, " Bio-Medical Materials and Engineering, vol. 19, no. 4-5, pp. 349-354, 2009.
37. A. Allameh, H. Ahmadi-Ashtiani, M. S. Emami Aleagha, and H. Rastegar, "The metabolic function of hepatocytes differentiated from human mesenchymal stem cells is inversely related to cellular glutathione levels, " Cell Biochemistry and Function, vol. 32, no. 2, pp. 194-200, 2014.
38. L. Zhang, Y.-H. Zhao, Z. Guan, J.-S. Ye, N. de Isla, and J.-F. Stoltz, "Application potential of mesenchymal stemcells derived from Whartons jelly in liver tissue engineering, " Bio-Medical Materials and Engineering, vol. 25, no. 1, supplement, pp. 137-143, 2015.
39. J.-S. Ye, X.-S. Su, J.-F. Stoltz, N. de Isla, and L. Zhang, "Signalling pathways involved in the process of mesenchymal stem cells differentiating into hepatocytes, " Cell Proliferation, vol. 48, no. 2, pp. 157-165, 2015.
40. N. Feng, Q. Han, J. Li et al., "Generation of highly purified neural stem cells from human adipose-derived mesenchymal stem cells by Sox1 activation, " Stem Cells and Development, vol. 23, no. 5, pp. 515-529, 2014.
41. M. M. Martini, T. D. S. Jeremias, M. C. Kohler, L. L. Marostica, A. G. Trentin, and M. Alvarez-Silva, "Human placenta-derived mesenchymal stem cells acquire neural phenotype under the appropriate niche conditions, "DNA and Cell Biology, vol. 32, no. 2, pp. 58-65, 2013.
42. K. Ma, L. Fox, G. Shi et al., "Generation of neural stem celllike cells frombonemarrow-derived human mesenchymal stem cells, " Neurological Research, vol. 33, no. 10, pp. 1083-1093, 2011.
43. G. Chamberlain, J. Fox, B. Ashton, and J. Middleton, "Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing, " Stem Cells, vol. 25, no. 11, pp. 2739-2749, 2007.
44. K. Chen, D. Wang, W. T. Du et al., "Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism, " Clinical Immunology, vol. 135, no. 3, pp. 448-458, 2010.
45. A. Corcione, F. Benvenuto, E. Ferretti et al., "Humanmesenchymal stem cells modulate B-cell functions, " Blood, vol. 107, no. 1, pp. 367-372, 2006.
46. L. Reppel, T. Margossian, L. Yaghi et al., "Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Whartons jelly: A critical parameter to consider in a therapeutic context, " Current Stem Cell Research &Therapy, vol. 9, no. 4, pp. 306-318, 2014.
47. D. E. Wright, A. J. Wagers, A. P. Gulati, F. L. Johnson, and I. L. Weissman, "Physiological migration of hematopoietic stemand progenitor cells, " Science, vol. 294, no. 5548, pp. 1933-1936, 2001.
48. H. H. Chen, V. Decot, J. P. Ouyang, J. F. Stoltz, D. Bensoussan, and N. G. De Isla, "In vitro initial expansion of mesenchymal stem cells is influenced by the culture parameters used in the isolation process, " Bio-Medical Materials and Engineering, vol. 19, no. 4-5, pp. 301-309, 2009.
49. E. U. Alt, C. Senst, S. N. Murthy et al., "Aging alters tissue resident mesenchymal stemcell properties, " Stem Cell Research, vol. 8, no. 2, pp. 215-225, 2012.
50. M. S. Rao and M. P. Mattson, "Stem cells and aging: expanding the possibilities, " Mechanisms of Ageing and Development, vol. 122, no. 7, pp. 713-734, 2001.
51. B.M. Schipper, K. G. Marra, W. Zhang, A. D. Donnenberg, and J. P. Rubin, "Regional anatomic and age effects on cell function of human adipose-derived stem cells, " Annals of Plastic Surgery, vol. 60, no. 5, pp. 538-544, 2008.
52. S. Zhou, J. S. Greenberger, M. W. Epperly et al., "Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts, " Aging Cell, vol. 7, no. 3, pp. 335-343, 2008.
53. M. Zhu, E. Kohan, J. Bradley, M. Hedrick, P. Benhaim, and P. Zuk, "The effect of age on osteogenic, adipogenic and proliferative potential of female adipose-derived stem cells, " Journal of Tissue Engineering and Regenerative Medicine, vol. 3, no. 4, pp. 290-301, 2009.
54. Y. Li, N. Charif, D. Mainard, D. Bensoussan, J.-F. Stoltz, and N. de Isla, "Donor's age dependent proliferation decrease of human bone marrow mesenchymal stem cells is linked to diminished clonogenicity, " Bio-Medical Materials and Engineering, vol. 24, no. 1, supplement, pp. 47-52, 2014.
55. G. Brooke, H. Tong, J.-P. Levesque, and K. Atkinson, "Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived fromhuman bonemarrowand placenta, " StemCells and Development, vol. 17, no. 5, pp. 929-940, 2008.
56. J. W. Goodman and G. S. Hodgson, "Evidence for stem cells in the peripheral blood of mice, " Blood, vol. 19, pp. 702-714, 1962.
57. Y. Jiang, B. Vaessen, T. Lenvik, M. Blackstad, M. Reyes, and C. M. Verfaillie, "Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain, " Experimental Hematology, vol. 30, no. 8, pp. 896-904, 2002.
58. J. Tolar, M. J. OShaughnessy, A. Panoskaltsis-Mortari et al., "Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells, " Blood, vol. 107, no. 10, pp. 4182-4188, 2006.
59. M.-C. Kastrinaki, I. Andreakou, P. Charbord, and H. A. Papadaki, "Isolation of human bone marrow mesenchymal stem cells using different membrane markers: comparison of colony/cloning efficiency, differentiation potential, and molecular profile, " Tissue Engineering Part C: Methods, vol. 14, no. 4, pp. 333-339, 2008.
60. M. F. Pera, "Stem cells: The dark side of induced pluripotency, " Nature, vol. 471, no. 7336, pp. 46-47, 2011.
61. G. Brooke, M. Cook, C. Blair et al., "Therapeutic applications of mesenchymal stromal cells, " Seminars in Cell & Developmental Biology, vol. 18, no. 6, pp. 846-858, 2007.
62. A. Giordano, U. Galderisi, and I. R. Marino, "From the laboratory bench to the patients bedside: An update on clinical trials with Mesenchymal Stem Cells, " Journal of Cellular Physiology, vol. 211, no. 1, pp. 27-35, 2007.
63. K. Tarte, J. Gaillard, J.-J. Lataillade et al., "Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation, " Blood, vol. 115, no. 8, pp. 1549-1553, 2010.
64. G. Brooke, T. Rossetti, R. Pelekanos et al., "Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials, " British Journal of Haematology, vol. 144, no. 4, pp. 571-579, 2009.
65. J. F. Stoltz, D. Dumas, X. Wang et al., "Influence ofmechanical forces on cells and tissues, " Biorheology, vol. 37, no. 1-2, pp. 3-14, 2000.
66. T. Lapidot, C. Sirard, J. Vormoor et al., "A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, " Nature, vol. 367, no. 6464, pp. 645-648, 1994.
67. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, "Prospective identification of tumorigenic breast cancer cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 3983-3988, 2003.
68. S. K. Singh, C. Hawkins, I. D. Clarke et al., "Identification of human brain tumour initiating cells, " Nature, vol. 432, no. 7015, pp. 396-401, 2004.
69. A. T. Collins, P. A. Berry, C. Hyde, M. J. Stower, and N. J. Maitland, "Prospective identification of tumorigenic prostate cancer stem cells, " Cancer Research, vol. 65, no. 23, pp. 10946-10951, 2005.
70. C. Li, D. G. Heidt, P. Dalerba et al., "Identification of pancreatic cancer stem cells, " Cancer Research, vol. 67, no. 3, pp. 1030-1037, 2007.
71. P. Dalerba, R. W. Cho, and M. F. Clarke, "Cancer stem cells: models and concepts, " Annual Review of Medicine, vol. 58, pp. 267-284, 2007.
72. W.-T. Liao, Y.-P. Ye, Y.-J. Deng, X.-W. Bian, and Y.-Q. Ding, "Metastatic cancer stem cells: fromthe concept to therapeutics, " American Journal of Stem Cells, vol. 3, no. 2, pp. 46-62, 2014.
73. A. D. Kim, D. L. Stachura, and D. Traver, "Cell signaling pathways involved in hematopoietic stem cell specification, " Experimental Cell Research, vol. 329, no. 2, pp. 227-233, 2014.
74. Y. Wu, Z. Wang, Y. Cao et al., "Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy, " Annals of Hematology, vol. 92, no. 12, pp. 1675-1684, 2013.
75. Y. Wu, Y. Cao, X. Li et al., "Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells for severe aplastic anemia: successful engraftment and mild GVHD, " Stem Cell Research, vol. 12, no. 1, pp. 132-138, 2014.
76. J. J. Auletta, S. K. Eid, P. Wuttisarnwattana et al., "Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bonemarrow transplantation, " StemCells, vol. 33, no. 2, pp. 601-614, 2015.
77. M. S. Cairo and J. E. Wagner, "Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation, " Blood, vol. 90, no. 12, pp. 4665-4678, 1997.
78. J. Cany, H. Dolstra, and N. Shah, "Umbilical cordblood-derived cellular products for cancer immunotherapy, " Cytotherapy, vol. 17, no. 6, pp. 739-748, 2015.
79. V. Rocha, C. Chastang, G. Souillet et al., "Related cord blood transplants: The Eurocord experience from78 transplants, " Bone Marrow Transplantation, vol. 21, supplement 3, pp. S59-S62, 1998.
80. E. Gluckman, "Ten years of cord blood transplantation: from bench to bedside, " British Journal of Haematology, vol. 147, no. 2, pp. 192-199, 2009.
81. M. E. Horwitz and F. Frassoni, "Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulation, " Cytotherapy, vol. 17, no. 6, pp. 730-738, 2015.
82. K. K. Ballen, E. Gluckman, and H. E. Broxmeyer, "Umbilical cord blood transplantation: The first 25 years and beyond, " Blood, vol. 122, no. 4, pp. 491-498, 2013.
83. M. Gigante and E. Ranieri, "Role of cytotoxic CD4+ T cells in cancer immunotherapy, " Immunotherapy, vol. 2, no. 5, pp. 607-608, 2010.
84. G. Zhang, H. Zhao, J. Wu et al., "Adoptive immunotherapy for non-small cell lung cancer byNKand cytotoxic T lymphocytes mixed effector cells: retrospective clinical observation, " International Immunopharmacology, vol. 21, no. 2, pp. 396-405, 2014.
85. V. Decot, L. Voillard, V. Latger-Cannard et al., "Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact onNKG2D, KIR2DL1, andKIR2DL2 expression, " Experimental Hematology, vol. 38, no. 5, pp. 351-362, 2010.
86. M. Cheng, Y. Chen, W. Xiao, R. Sun, and Z. Tian, "NKcell-based immunotherapy for malignant diseases, " Cellular & Molecular Immunology, vol. 10, no. 3, pp. 230-252, 2013.
87. C. Eguizabal, O. Zenarruzabeitia, J. Monge et al., "Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective, " Frontiers in Immunology, vol. 5, article 439, 2014.
88. Y. Zhang, L. Wang, D. Li, and N. Li, "Taming regulatory T cells by autologous T cell immunization: A potential new strategy for cancer immune therapy, " International Immunopharmacology, vol. 9, no. 5, pp. 593-595, 2009.
89. L. Xu, W. Xu, Z. Jiang, F. Zhang, Y. Chu, and S. Xiong, "Depletion of CD4+ CD25 high regulatory T cells from tumor infiltrating lymphocytes predominantly induces Th1 type immune response in vivo which inhibits tumor growth in adoptive immunotherapy, " Cancer Biology and Therapy, vol. 8, no. 1, pp. 66-72, 2009.
90. F. Dazzi and F. M. Marelli-Berg, "Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells, " European Journal of Immunology, vol. 38, no. 6, pp. 1479-1482, 2008.
91. K. Le Blanc, I. Rasmusson, B. Sundberg et al., "Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, " The Lancet, vol. 363, no. 9419, pp. 1439-1441, 2004.
92. N. Kim, K.-I. Im, J.-Y. Lim et al., "Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice, " Annals of Hematology, vol. 92, no. 10, pp. 1295-1308, 2013.
93. J. D. Glenn and K. A. Whartenby, "Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy, " World Journal of Stem Cells, vol. 6, no. 5, pp. 526-539, 2014.
94. M. Introna and A. Rambaldi, "Mesenchymal stromal cells for prevention and treatment of graft-versus-host disease, " Current Opinion in Organ Transplantation, vol. 20, no. 1, pp. 72-78, 2015.
95. N. Amariglio, A. Hirshberg, B. W. Scheithauer et al., "Donorderived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient, " PLoS Medicine, vol. 6, no. 2, Article ID e1000029, 2009.
96. J. Tritz-Schiavi, N. Charif, C. Henrionnet et al., "Original approach for cartilage tissue engineering with mesenchymal stem cells, " Bio-Medical Materials and Engineering, vol. 20, no. 3, pp. 167-174, 2010.
97. A. I. Caplan and S. P. Bruder, "Mesenchymal stem cells: building blocks for molecular medicine in the 21st century, " Trends in Molecular Medicine, vol. 7, no. 6, pp. 259-264, 2001.
98. A. Schäffler and C. Büchler, "Concise review: Adipose tissuederived stromal cells-basic and clinical implications for novel cell-based therapies, " StemCells, vol. 25, no. 4, pp. 818-827, 2007.
99. J. F. Stoltz, Ed., Regenerative Medicine and Cell Therapy, IOS Press, Amsterdam, The Netherlands, 2012.
100. A. I. Caplan, "Adultmesenchymal stemcells for tissue engineering versus regenerative medicine, " Journal of Cellular Physiology, vol. 213, no. 2, pp. 341-347, 2007.
101. H. Gai, E. L.-H. Leung, P. D. Costantino et al., "Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts, " Cell Biology International, vol. 33, no. 11, pp. 1184-1193, 2009.
102. R. E. Bittner, C. Schöfer, K. Weipoltshammer et al., "Recruitment of bone-marrow-derived cells by skeletal and cardiacmuscle in adult dystrophic mdx mice, " Anatomy and Embryology, vol. 199, no. 5, pp. 391-396, 1999.
103. A. Deb, S. Wang, K.A. Skelding, D. Miller, D. Simper, and N.M. Caplice, "Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bonemarrow transplantation patients, " Circulation, vol. 107, no. 9, pp. 1247-1249, 2003.
104. S. Itescu, A. A. Kocher, and M. D. Schuster, "Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function, " Heart Failure Reviews, vol. 8, no. 3, pp. 253-258, 2003.
105. S. Kang, Y. J. Yang, C. J. Li, and R. L. Gao, "Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: A systematic review and meta-Analysis for randomized controlled trials, " Coronary Artery Disease, vol. 19, no. 5, pp. 327-335, 2008.
106. M. A. Laflamme, D. Myerson, J. E. Saffitz, and C. E. Murry, "Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts, " Circulation Research, vol. 90, no. 6, pp. 634-640, 2002.
107. R.-J. Swijnenburg, M. Tanaka, H. Vogel et al., "Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium, " Circulation, vol. 112, no. 9, supplement, pp. I166-I172, 2005.
108. J. Tang, Q. Xie, G. Pan, J. Wang, and M. Wang, "Mesenchymal stem cells participate in angiogenesis and improve heart function in ratmodel ofmyocardial ischemia with reperfusion, " European Journal of Cardio-Thoracic Surgery, vol. 30, no. 2, pp. 353-361, 2006.
109. C. Toma, M. F. Pittenger, K. S. Cahill, B. J. Byrne, and P. D. Kessler, "Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart, " Circulation, vol. 105, no. 1, pp. 93-98, 2002.
110. A. P. Gee, S. Richman, A. Durett et al., "Multicenter cell processing for cardiovascular regenerative medicine applications: The Cardiovascular Cell Therapy Research Network (CCTRN) experience, " Cytotherapy, vol. 12, no. 5, pp. 684-691, 2010.
111. B. Trachtenberg, D. L. Velazquez, A. R. Williams et al., "Rationale and design of the transendocardial injection of autologous human cells (bone marrow or mesenchymal) in chronic ischemic left ventricular dysfunction and heart failure secondary to myocardial infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy, " American Heart Journal, vol. 161, no. 3, pp. 487-493, 2011.
112. J. M. Hare, J. H. Traverse, T. D. Henry et al., "A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction, " Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2277-2286, 2009.
113. S.-L. Chen, W.-W. Fang, F. Ye et al., "Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction, "TheAmerican Journal of Cardiology, vol. 94, no. 1, pp. 92-95, 2004.
114. K. H. Wu, B. Zhou, X. M. Mo et al., "Therapeutic potential of human umbilical cord-derived stem cells in ischemic diseases, " Transplantation Proceedings, vol. 39, no. 5, pp. 1620-1622, 2007.
115. N. Berthelemy, H. Kerdjoudj, P. Schaaf et al., "O2 level controls hematopoietic circulating progenitor cells differentiation into endothelial or smooth muscle cells, " PLoS ONE, vol. 4, no. 5, Article ID e5514, 2009.
116. M. Faustini, M. Bucco, T. Chlapanidas et al., "Nonexpanded mesenchymal stemcells for regenerativemedicine: yield in stromal vascular fraction from adipose tissues, " Tissue Engineering Part C: Methods, vol. 16, no. 6, pp. 1515-1521, 2010.
117. S. Kachgal and A. J. Putnam, "Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms, " Angiogenesis, vol. 14, no. 1, pp. 47-59, 2011.
118. D. Kaigler, P. H. Krebsbach, P. J. Polverini, and D. J. Mooney, "Role of vascular endothelial growth factor in bone marrow stromal cellmodulationof endothelial cells, " Tissue Engineering, vol. 9, no. 1, pp. 95-103, 2003.
119. C. Sengenes, A. Miranville, M. Maumus, S. de Barros, R. Busse, and A. Bouloumíe, "Chemotaxis and differentiation of human adipose tissue CD34+/CD31? progenitor cells: role of stromal derived factor-1 released by adipose tissue capillary endothelial cells, " Stem Cells, vol. 25, no. 9, pp. 2269-2276, 2007.
120. F. Zhang, S. Tsai, K. Kato et al., "Transforming growth factor promotes recruitment of bone marrow cells and bone marrowderived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells, " The Journal of Biological Chemistry, vol. 284, no. 26, pp. 17564-17574, 2009.
121. U.-M. Riegelsberger, A. Deten, C. Pösel et al., "Intravenous human umbilical cord blood transplantation for stroke: impact on infarct volume and caspase-3-dependent cell death in spontaneously hypertensive rats, " Experimental Neurology, vol. 227, no. 1, pp. 218-223, 2011.
122. J. S. Lee, J. M. Hong, G. J. Moon, P. H. Lee, Y. H. Ahn, and O. Y. Bang, "A long-Term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke, " Stem Cells, vol. 28, no. 6, pp. 1099-1106, 2010.
123. Y. Jiang, W. Zhu, J. Zhu, L. Wu, G. Xu, and X. Liu, "Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery, " Cell Transplantation, vol. 22, no. 12, pp. 2291-2298, 2013.
124. D. C. Hess, C. A. Sila, A. J. Furlan, L. R. Wechsler, J. A. Switzer, and R. W. Mays, "A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke, " International Journal of Stroke, vol. 9, no. 3, pp. 381-386, 2014.
125. S.-T. Lee, K. Chu, K.-H. Jung et al., "Slowed progression inmodels of Huntington disease by adipose stem cell transplantation, " Annals of Neurology, vol. 66, no. 5, pp. 671-681, 2009.
126. T. Lopatina, N. Kalinina, M. Karagyaur et al., "Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de Novo, " PLoS ONE, vol. 6, no. 3, Article ID e17899, 2011.
127. J. Alper, "Geron gets green light for human trial of ES cellderived product, " Nature Biotechnology, vol. 27, no. 3, pp. 213-214, 2009.
128. A. R. Chapman and C. C. Scala, "Evaluating the first-in-human clinical trial of a human embryonic stem cell-based therapy, " Kennedy Institute of Ethics Journal, vol. 22, no. 3, pp. 243-261, 2012.
129. P. Bigini, P. Veglianese, G. Andriolo et al., "Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration, " Rejuvenation Research, vol. 14, no. 6, pp.623-639, 2011.
130. N. K. Venkataramana, S. K. V. Kumar, S. Balaraju et al., "Openlabeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinsons disease, " Translational Research, vol. 155, no. 2, pp. 62-70, 2010.
131. J. Y. Shin, H. J. Park, H. N. Kim et al., "Mesenchymal stem cells enhance autophagy and increase-Amyloid clearance in Alzheimer disease models, " Autophagy, vol. 10, no. 1, pp. 32-44, 2014.
132. C. M. Lewis and M. Suzuki, "Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis, " Stem Cell Research andTherapy, vol. 5, no. 2, article no. 32, 2014.
133. N. de Isla, C. Huseltein, N. Jessel et al., "Introduction to tissue engineering and application for cartilage engineering, " Bio-Medical Materials and Engineering, vol. 20, no. 3-4, pp. 127-133, 2010.
134. F. Mao, W.-R. Xu, H. Qian et al., "Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis, " Inflammation Research, vol. 59, no. 3, pp. 219-225, 2010.
135. J. F. Stoltz, Ed., Mechanobiology: Cartilage and Chondrocyte, IOS Press, Washington, DC, USA, 2006.
136. J. A. Buckwalter, M. Lotz, and J. F. Stoltz, Osteoarthritis, Inflammation, andDegradation:AContinuum, IOS Press, Amsterdam, The Netherlands, 2007.
137. A. Arthur, A. Zannettino, and S. Gronthos, "The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair, " Journal of Cellular Physiology, vol. 218, no. 2, pp. 237-245, 2009.
138. S. P. Bruder, A. A. Kurth, M. Shea, W. C. Hayes, N. Jaiswal, and S. Kadiyala, "Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells, " Journal of Orthopaedic Research, vol. 16, no. 2, pp. 155-162, 1998.
139. S. Wakitani, T. Mitsuoka, N. Nakamura, Y. Toritsuka, Y. Nakamura, and S. Horibe, "Autologous bone marrow stromal cell transplantation for repair of full-Thickness articular cartilage defects in human patellae: Two case reports, " Cell Transplantation, vol. 13, no. 5, pp. 595-600, 2004.
140. C. Chen, D. T. Tambe, L. Deng, and L. Yang, "Biomechanical properties and mechanobiology of the articular chondrocyte, " The American Journal of Physiology-Cell Physiology, vol. 305, no. 12, pp. C1202-C1208, 2013.
141. R. E. Wilusz, J. Sanchez-Adams, and F. Guilak, "The structure and function of the pericellular matrix of articular cartilage, " Matrix Biology, vol. 39, pp. 25-32, 2014.
142. H. A. Breinan, T. Minas, H.-P. Hsu, S. Nehrer, C. B. Sledge, and M. Spector, "Effect of cultured autologous chondrocytes on repair of chondral defects in a canine model, " The Journal of Bone&Joint Surgery Series A, vol. 79, no. 10, pp. 1439-1451, 1997.
143. B. Schmitt, J. Ringe, T. Häupl et al., "BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture, " Differentiation, vol. 71, no. 9-10, pp. 567-577, 2003.
144. S. Wakitani, K. Imoto, T. Yamamoto, M. Saito, N. Murata, and M. Yoneda, "Human autologous culture expanded bone marrow-mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees, " Osteoarthritis and Cartilage, vol. 10, no. 3, pp. 199-206, 2002.
145. M. Brittberg, A. Lindahl, A. Nilsson, C. Ohlsson, O. Isaksson, and L. Peterson, "Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation, " The New England Journal of Medicine, vol. 331, no. 14, pp. 889-895, 1994.
146. C. Huselstein, P. Netter, N. de Isla et al., "Mechanobiology, chondrocyte and cartilage, " Bio-Medical Materials and Engineering, vol. 18, no. 4-5, pp. 213-220, 2008.
147. P. Angele, J. U. Yoo, C. Smith et al., "Cyclic hydrostatic pressure enhances the chondrogenic phenotype of human mesenchymal progenitor cells differentiated in vitro, " Journal of Orthopaedic Research, vol. 21, no. 3, pp. 451-457, 2003.
148. F. Barry, R. E. Boynton, B. Liu, and J. M. Murphy, "Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components, " Experimental Cell Research, vol. 268, no. 2, pp. 189-200, 2001.
149. J. J. Campbell, D.A. Lee, and D. L. Bader, "Dynamic compressive strain influences chondrogenic gene expression in human mesenchymal stem cells, " Biorheology, vol. 43, no. 3-4, pp. 455-470, 2006.
150. L. de Girolamo, S. Lopa, E. Arrigoni, M. F. Sartori, F. W. B. Preis, and A. T. Brini, "Human adipose-derived stem cells isolated from young and elderly women: Their differentiation potential and scaffold interaction during in vitro osteoblastic differentiation, " Cytotherapy, vol. 11, no. 6, pp. 793-803, 2009.
151. K. Hiraoka, S. Grogan, T. Olee, and M. Lotz, "Mesenchymal progenitor cells in adult human articular cartilage, " Biorheology, vol. 43, no. 3-4, pp. 447-454, 2006.
152. J. I. Huang, N. Kazmi, M. M. Durbhakula, T. M. Hering, J. U. Yoo, and B. Johnstone, "Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: A patient-matched comparison, " Journal of Orthopaedic Research, vol. 23, no. 6, pp. 1383-1389, 2005.
153. J.-F. Stoltz, C. Huselstein, J. Schiavi et al., "Human stemcells and articular cartilage tissue engineering, " Current Pharmaceutical Biotechnology, vol. 13, no. 15, pp. 2682-2691, 2012.
154. C.-Y. Fong, A. Subramanian, K. Gauthaman et al., "Human umbilical cord Whartons jelly stem cells undergo enhanced chondrogenic differentiation when grown on nanofibrous scaffolds and in a sequential two-stage culture medium environment, " Stem Cell Reviews and Reports, vol. 8, no. 1, pp. 195-209, 2012.
155. X. Chen, F. Zhang, X. He et al., "Chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells in type I collagen-hydrogel for cartilage engineering, " Injury, vol. 44, no. 4, pp. 540-549, 2013.
156. S. Liu, K. D. Hou, M. Yuan et al., "Characteristics of mesenchymal stemcells derived fromWhartons jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage, " Journal of Bioscience and Bioengineering, vol. 117, no. 2, pp. 229-235, 2014.
157. S. Ciavarella, F. Dammacco, M. de Matteo, G. Loverro, and F. Silvestris, "Umbilical cord mesenchymal stem cells: role of regulatory genes in their differentiation to osteoblasts, " Stem Cells and Development, vol. 18, no. 8, pp. 1211-1220, 2009.
158. K. L. Wong, K. B. L. Lee, B. C. Tai, P. Law, E. H. Lee, and J. H. P. Hui, "Injectable culturedbonemarrow-derivedmesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: A prospective, randomized controlled clinical trial with 2 years follow-up, " Arthroscopy, vol. 29, no. 12, pp. 2020-2028, 2013.
159. C. H. Jo, Y. G. Lee, W. H. Shin et al., "Intra-Articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: A proof-of-concept clinical trial, " Stem Cells, vol. 32, no. 5, pp. 1254-1266, 2014.
160. A. Vega, M. A. Martín-Ferrero, F. Del Canto et al., "Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: A randomized controlled trial, " Transplantation, 2015.
161. M. Dubsky, A. Jirkovska, R. Bem et al., "Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia, " Cytotherapy, vol. 16, no. 12, pp. 1733-1738, 2014.
162. R. Subrammaniyan, J. Amalorpavanathan, R. Shankar et al., "Our experience of application of Autologous Bone Marrow Stem Cells in critical limb ischemia in six diabetic patients-A five-year follow-up, " Journal of Stem cells & Regenerative Medicine, vol. 7, no. 2, p. 97, 2011.
163. V. Sordi, M. L. Malosio, F. Marchesi et al., "Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets, " Blood, vol. 106, no. 2, pp. 419-427, 2005.
164. A. G. Tzakis, C. Ricordi, R. Alejandro et al., "Pancreatic islet transplantation after upper abdominal exenteration and liver replacement, " The Lancet, vol. 336, no. 8712, pp. 402-405, 1990.
165. A. M. J. Shapiro, J. R. T. Lakey, E. A. Ryan et al., "Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen, " The New England Journal of Medicine, vol. 343, no. 4, pp. 230-238, 2000.
166. N. C. Close, B. J. Hering, and T. L. Eggerman, "Results from the inaugural year of the Collaborative Islet Transplant Registry, " Transplantation Proceedings, vol. 37, no. 2, pp. 1305-1308, 2005.
167. A. M. J. Shapiro, J. R. T. Lakey, B. W. Paty, P. A. Senior, D. L. Bigam, and E. A. Ryan, "Strategic opportunities in clinical islet transplantation, " Transplantation, vol. 79, no. 10, pp. 1304-1307, 2005.
168. P. Czubak, A. Bojarska-Junak, J. Tabarkiewicz, and L. Putowski, "A modified method of insulin producing cells generation from bone marrow-derived mesenchymal stem cells, " Journal of Diabetes Research, vol. 2014, Article ID 628591, 7 pages, 2014.
169. L. Khorsandi, F. Nejad-Dehbashi, A. Ahangarpour, and M. Hashemitabar, "Three-dimensional differentiation of bone marrow-derived mesenchymal stem cells into insulinproducing cells, " Tissue and Cell, vol. 47, no. 1, pp. 66-72, 2015.
170. S. Kadam, S. Muthyala, P. Nair, and R. Bhonde, "Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes, " The Review of Diabetic Studies, vol. 7, no. 2, pp. 168-182, 2010.
171. H. Qu, X. Liu, Y. Ni et al., "Laminin 411 acts as a potent inducer of umbilical cord mesenchymal stem cell differentiation into insulin-producing cells, " Journal of Translational Medicine, vol. 12, no. 1, article 135, 2014.
172. P.-J. Tsai, H.-S. Wang, G.-J. Lin et al., "Undifferentiated Whartons jelly mesenchymal stem cell transplantation induces insulin-producing cell differentiation and suppression of T cell-mediated autoimmunity in non-obese diabetic mice, " Cell Transplantation, 2014.
173. K. A. DAmour, A. D. Agulnick, S. Eliazer, O. G. Kelly, E. Kroon, and E. E. Baetge, "Efficient differentiation of human embryonic stem cells to definitive endoderm, " Nature Biotechnology, vol. 23, no. 12, pp. 1534-1541, 2005.
174. S. Chen, M. Borowiak, J. L. Fox et al., "A small molecule that directs differentiation of human ESCs into the pancreatic lineage, " Nature Chemical Biology, vol. 5, no. 4, pp. 258-265, 2009.
175. E. Kroon, L. A. Martinson, K. Kadoya et al., "Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo, " Nature Biotechnology, vol. 26, no. 4, pp. 443-452, 2008.
176. K. Tateishi, J. He, O. Taranova, G. Liang, A. C. DAlessio, and Y. Zhang, "Generation of insulin-secreting islet-like clusters from human skin fibroblasts, " Journal of Biological Chemistry, vol. 283, no. 46, pp. 31601-31607, 2008.
177. T. Thatava, T. J. Nelson, R. Edukulla et al., "IndolactamV/GLP-1-mediated differentiation of human iPS cells into glucoseresponsive insulin-secreting progeny, " GeneTherapy, vol. 18, no. 3, pp. 283-293, 2011.
178. R. Jiang, Z. Han, G. Zhuo et al., "Transplantation of placentaderivedmesenchymal stemcells in type 2 diabetes: A pilot study, " Frontiers of Medicine in China, vol. 5, no. 1, pp. 94-100, 2011.
179. J. Hu, X. Yu, Z. Wang et al., "Long term effects of the implantation of Whartons jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus, " Endocrine Journal, vol. 60, no. 3, pp. 347-357, 2013.
180. D. Kong, X. Zhuang, D. Wang et al., "Umbilical cordmesenchymal stemcell transfusion ameliorated hyperglycemia in patients with type 2 diabetesmellitus, " Clinical Laboratory, vol. 60, no. 12, pp. 1969-1976, 2014.
181. P. Carlsson, E. Schwarcz, O. Korsgren, and K. Le Blanc, "Preserved cell function in type 1 diabetes by mesenchymal stromal cells, " Diabetes, vol. 64, no. 2, pp. 587-592, 2015.
182. S. T. Rashid, S. Corbineau, N. Hannan et al., "Modeling inheritedmetabolic disorders of the liver using human induced pluripotent stemcells, " Journal of Clinical Investigation, vol. 120, no. 9, pp. 3127-3136, 2010.
183. L. Zhang, J.-S. Ye, V. Decot, J.-F. Stoltz, and N. de Isla, "Research on stemcells as candidates to be differentiated into hepatocytes, " Bio-MedicalMaterials and Engineering, vol. 22, no. 1-3, pp. 105-111, 2012.
184. Q. Zhao, H. Ren, X. Li et al., "Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells, " Cytotherapy, vol. 11, no. 4, pp. 414-426, 2009.
185. T. S. Ramasamy, J. S. L. Yu, C. Selden, H. Hodgson, and W. Cui, "Application of three-dimensional culture conditions to human embryonic stem cell-derived definitive endoderm cells enhances hepatocyte differentiation and functionality, " Tissue Engineering Part A, vol. 19, no. 3-4, pp. 360-367, 2013.
186. J. Jozefczuk, A. Prigione, L. Chavez, and J. Adjaye, "Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation, " Stem Cells and Development, vol. 20, no. 7, pp. 1259-1275, 2011.
187. K. Si-Tayeb, F. K. Noto, M. Nagaoka et al., "Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells, " Hepatology, vol. 51, no. 1, pp. 297-305, 2010.
188. M. Mohamadnejad, K. Alimoghaddam, M. Bagheri et al., "Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis, " Liver International, vol. 33, no. 10, pp. 1490-1496, 2013.
189. L. Wang, J. Li, H. Liu et al., "A pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis, " Journal of Gastroenterology and Hepatology, vol. 28, no. 1, pp. 85-92, 2013.
190. M. Shi, Z. Zhang, R. Xu et al., "Human mesenchymal stem cell transfusion is safe and improves liver function in acute-onchronic liver failure patients, " StemCells TranslationalMedicine, vol. 1, no. 10, pp. 725-731, 2012.
191. M.-E. M. Amer, S. Z. El-Sayed, W. A. El-Kheir et al., "Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells, " European Journal of Gastroenterology & Hepatology, vol. 23, no. 10, pp. 936-941, 2011.
192. A. Atala, S. B. Bauer, S. Soker, J. J. Yoo, and A. B. Retik, "Tissue-engineered autologous bladders for patients needing cystoplasty, " The Lancet, vol. 367, no. 9518, pp. 1241-1246, 2006.
193. L. Ma, Y. Yang, S. C. Sikka et al., "Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 6, pp. 2090-2095, 2012.
194. G. Nolazco, I. Kovanecz, D. Vernet et al., "Effect of musclederived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat, " BJU International, vol. 101, no. 9, pp. 1156-1164, 2008.
195. J. Y. Bahk, J. H. Jung, H. Han, S. K. Min, and Y. S. Lee, "Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: preliminary report of 7 cases, " Experimental and Clinical Transplantation, vol. 8, no. 2, pp. 150-160, 2010.
196. F. Castiglione, P. Hedlund, F. van der Aa et al., "Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronies disease, " European Urology, vol. 63, no. 3, pp. 551-560, 2013.
197. T. K. Ng, V. R. Fortino, D. Pelaez, and H. S. Cheung, "Progress of mesenchymal stem cell therapy for neural and retinal diseases, " World Journal of Stem Cells, vol. 6, no. 2, pp. 111-119, 2014.
198. A. Tzameret, I. Sher, M. Belkin et al., "Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy, " Experimental Eye Research, vol. 118, pp. 135-144, 2014.
199. Y. Hu, H. B. Tan, X.M. Wang, H. Rong, and H. P. Cui, "Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma, " Clinical Interventions in Aging, vol. 8, pp. 1467-1470, 2013.
200. L. Ronzoni, P. Bonara, D. Rusconi, C. Frugoni, I. Libani, and M. D. Cappellini, "Erythroid differentiation and maturation from peripheral CD34+ cells in liquid culture: cellular and molecular characterization, " Blood Cells, Molecules, and Diseases, vol. 40, no. 2, pp. 148-155, 2008.
201. E. Olivier, C. Qiu, and E. E. Bouhassira, "Novel, high-yield red blood cell production methods from CD34-positive cells derived from human embryonic stem, yolk sac, fetal liver, cord blood, and peripheral blood, " StemCells TranslationalMedicine, vol. 1, no. 8, pp. 604-614, 2012.
202. F. Ma, Y. Ebihara, K. Umeda et al., "Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13087-13092, 2008.
203. Y. Ebihara, F. Ma, and K. Tsuji, "Generation of red blood cells fromhuman embryonic/induced pluripotent stemcells for blood transfusion, " International Journal of Hematology, vol. 95, no. 6, pp. 610-616, 2012.
204. C.-T. Yang, A. French, P. A. Goh et al., "Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co-express gamma and beta globins, " British Journal of Haematology, vol. 166, no. 3, pp. 435-448, 2014.
205. A. Atala, "Engineering organs, " Current Opinion in Biotechnology, vol. 20, no. 5, pp. 575-592, 2009.
206. G. Orlando, P. Baptista, M. Birchall et al., "Regenerative medicine as applied to solid organ transplantation: current status and future challenges, " Transplant International, vol. 24, no. 3, pp. 223-232, 2011.
207. S. F. Badylak, D. Taylor, and K. Uygun, "Whole-organ tissue engineering: decellularization and recellularization of threedimensional matrix scaffolds, " Annual Review of Biomedical Engineering, vol. 13, pp. 27-53, 2011.
208. P. M. Baptista, G. Orlando, S.-H. Mirmalek-Sani, M. Siddiqui, A. Atala, and S. Soker, "Whole organ decellularization-A tool for bioscaffold fabrication and organ bioengineering, " in Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 09), pp. 6526-6529, 2009.
209. S. V. Murphy and A. Atala, "Organ engineering-combining stem cells, biomaterials, and bioreactors to produce bioengineered organs for transplantation, " BioEssays, vol. 35, no. 3, pp. 163-172, 2013.
210. M. E. Scarritt, N. C. Pashos, and B. A. Bunnell, "A review of cellularization strategies for tissue engineering ofwhole organs, " Frontiers in Bioengineering and Biotechnology, vol. 3, article 43, 2015.
211. A. Mathur and J. F. Martin, "Stem cells and repair of the heart, " The Lancet, vol. 364, no. 9429, pp. 183-192, 2004.
212. H. C. Ott, T. S. Matthiesen, S.-K. Goh et al., "Perfusiondecellularized matrix: using natures platform to engineer a bioartificial heart, " Nature Medicine, vol. 14, no. 2, pp. 213-221, 2008.
213. A. A. Khan, S. K. Vishwakarma, A. Bardia, and J. Venkateshwarulu, "Repopulation of decellularized whole organ scaffold using stem cells: An emerging technology for the development of neo-organ, " Journal of Artificial Organs, vol. 17, no. 4, pp. 291-300, 2014.
214. J. M. Singelyn and K. L. Christman, "Injectable materials for the treatment of myocardial infarction and heart failure: The promise of decellularized matrices, " Journal of Cardiovascular Translational Research, vol. 3, no. 5, pp. 478-486, 2010.
215. T. Ota, T. W. Gilbert, S. F. Badylak, D. Schwartzman, and M. A. Zenati, "Electromechanical characterization of a tissue-engineered myocardial patch derived from extracellular matrix, " Journal ofThoracic andCardiovascular Surgery, vol. 133, no. 4, pp. 979-985, 2007.
216. I. A. Potapova, S. V. Doronin, D. J. Kelly et al., "Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 295, no. 6, pp. H2257-H2263, 2008.
217. E. Martinod, A. Seguin, M. Holder-Espinasse et al., "Tracheal regeneration following tracheal replacement with an allogenic aorta, " Annals of Thoracic Surgery, vol. 79, no. 3, pp. 942-948, 2005.
218. D. M. Radu, A. Seguin, P. Bruneval, A. F. Legendre, A. Carpentier, and E. Martinod, "Bronchial replacement with arterial allografts, " Annals ofThoracic Surgery, vol. 90, no. 1, pp.252-258, 2010.
219. G. M. Roomans, "Tissue engineering and the use of stem/progenitor cells for airway epithelium repair, " European Cells & Materials, vol. 19, pp. 284-299, 2010.
220. A. Seguin, D. Radu, M. Holder-Espinasse et al., "Tracheal replacement with cryopreserved, decellularized, or glutaraldehyde-Treated aortic allografts, " Annals of Thoracic Surgery, vol. 87, no. 3, pp. 861-867, 2009.
221. T. H. Petersen, E. A. Calle, L. Zhao et al., "Tissue-engineered lungs for in vivo implantation, " Science, vol. 329, no. 5991, pp. 538-541, 2010.
222. D. A. Chistiakov, "Endogenous and exogenous stem cells: A role in lung repair and use in airway tissue engineering and transplantation, " Journal of Biomedical Science, vol. 17, no. 1, article 92, 2010.
223. H. A. Chapman, "Toward lung regeneration, " The New England Journal of Medicine, vol. 364, no. 19, pp. 1867-1868, 2011.
224. J. Martin, K. Helm, P. Ruegg, M. Varella-Garcia, E. Burnham, and S. Majka, "Adult lung side population cells have mesenchymal stem cell potential, " Cytotherapy, vol. 10, no. 2, pp. 140-151, 2008.
225. L. Jarvinen, L. Badri, S. Wettlaufer et al., "Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator, " The Journal of Immunology, vol. 181, no. 6, pp. 4389-4396, 2008.
226. X. Gong, Z. Sun, D. Cui et al., "Isolation and characterization of lung resident mesenchymal stem cells capable of differentiating into alveolar epithelial type II cells, " Cell Biology International, vol. 38, no. 4, pp. 405-411, 2014.
227. K. Chow, J.P. Fessel, Kaoriihida-Stansbury et al., "Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling, " Pulmonary Circulation, vol. 3, no. 1, pp. 31-49, 2013.
228. K. M. Antoniou, H. A. Papadaki, G. Soufla et al., "Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in idiopathic pulmonary fibrosis (IPF), " Respiratory Medicine, vol. 104, no. 10, pp. 1535-1542, 2010.
229. Y. Zhang, S. Liao, M. Yang et al., "Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension, " Cell Transplantation, vol. 21, no. 10, pp. 2225-2239, 2012.
230. K. D. Liu, J. G. Wilson, H. Zhuo et al., "Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome, " Annals of Intensive Care, vol. 4, article 22, 2014.
231. J. G. Wilson, K. D. Liu, H. Zhuo et al., "Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1 clinical trial, " The Lancet Respiratory Medicine, vol. 3, no. 1, pp. 24-32, 2015.
232. H. C. Ott, B. Clippinger, C. Conrad et al., "Regeneration and orthotopic transplantation of a bioartificial lung, " Nature Medicine, vol. 16, no. 8, pp. 927-933, 2010.
233. J. E. Nichols, J. Niles, M. Riddle et al., "Production and assessment of decellularized pig and human lung scaffolds, " Tissue Engineering Part A, vol. 19, no. 17-18, pp. 2045-2062, 2013.
234. D. E. Wagner, N. R. Bonenfant, D. Sokocevic et al., "Threedimensional scaffolds of acellular human and porcine lungs for high throughput studies of lung disease and regeneration, " Biomaterials, vol. 35, no. 9, pp. 2664-2679, 2014.
235. R.W. Bonvillain, S. Danchuk, D. E. Sullivan et al., "A nonhuman primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization withmesenchymal stem cells, " Tissue Engineering-Part A, vol. 18, no. 23-24, pp. 2437-2452, 2012.
236. J. Cortiella, J. Niles, A. Cantu et al., "Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation, " Tissue Engineering Part A, vol. 16, no. 8, pp. 2565-2580, 2010.
237. S. Lecht, C. T. Stabler, A. L. Rylander et al., "Enhancedreseeding of decellularized rodent lungs with mouse embryonic stem cells, " Biomaterials, vol. 35, no. 10, pp. 3252-3262, 2014.
238. T. Tsuchiya, A. Sivarapatna, K. Rocco, A. Nanashima, T. Nagayasu, and L. E. Niklason, "Future prospects for tissue engineered lung transplantation: decellularization and recellularization-based whole lung regeneration, " Organogenesis, vol. 10, no. 2, pp. 196-207, 2014.
239. A. Soto-Gutierrez, L. Zhang, C. Medberry et al., "Awhole-organ regenerative medicine approach for liver replacement, " Tissue Engineering, Part C: Methods, vol. 17, no. 6, pp. 677-686, 2011.
240. H. Yagi, K. Fukumitsu, K. Fukuda et al., "Human-scale wholeorgan bioengineering for liver transplantation: A regenerative medicine approach, " Cell Transplantation, vol. 22, no. 2, pp. 231-242, 2013.
241. J.-S. Ye, J.-F. Stoltz, N. de Isla, Y. Liu, Y.-F. Yin, and L. Zhang, "An approach to preparing decellularized whole liver organ scaffold in rat, " Bio-Medical Materials and Engineering, vol. 25, no. 1, supplement, pp. 159-166, 2015.
242. W.-C. Jiang, Y.-H. Cheng, M.-H. Yen, Y. Chang, V.W. Yang, and O. K. Lee, "Cryo-chemical decellularization of the whole liver for mesenchymal stem cells-based functional hepatic tissue engineering, " Biomaterials, vol. 35, no. 11, pp. 3607-3617, 2014.
243. R. Ji, N. Zhang, N. You et al., "The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice, " Biomaterials, vol. 33, no. 35, pp. 8995-9008, 2012.
244. L. Behr, M. Hekmati, A. Lucchini et al., "Evaluation of the effect of autologousmesenchymal stem cell injection in a large-Animal model of bilateral kidney ischaemia reperfusion injury, " Cell Proliferation, vol. 42, no. 3, pp. 284-297, 2009.
245. L. Behr, M. Hekmati, G. Fromont et al., "Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postischemic kidney, " Nephron Physiology, vol. 107, no. 3, pp. p65-p76, 2007.
246. S. K. Nigam, W. Wu, and K. T. Bush, "Organogenesis forum lecture: in vitro kidney development, tissue engineering and systems biology, " Organogenesis, vol. 4, no. 3, pp. 137-143, 2008.
247. E. Rosines, K. Johkura, X. Zhang et al., "Constructing kidneylike tissues from cells based on programs for organ development: Toward a method of in vitro tissue engineering of the kidney, " Tissue Engineering, Part A, vol. 16, no. 8, pp. 2441-2455, 2010.
248. E. A. Ross, M. J. Williams, T. Hamazaki et al., "Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds, " Journal of theAmerican Society of Nephrology, vol. 20, no. 11, pp. 2338-2347, 2009.
249. K. H. Nakayama, C. A. Batchelder, C. I. Lee, and A. F. Tarantal, "Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering, " Tissue Engineering Part A, vol. 16, no. 7, pp. 2207-2216, 2010.
250. F. Tasnim, R. Deng, M. Hu et al., "Achievements and challenges in bioartificial kidney development, " Fibrogenesis & Tissue Repair, vol. 3, no. 14, 2010.
251. S. R. Baglio, D. M. Pegtel, and N. Baldini, "Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cellfree therapy, " Frontiers in Physiology, vol. 3, article 359, 2012.
252. R. C. Lai, R. W. Y. Yeo, and S. K. Lim, "Mesenchymal stemcell exosomes, " Seminars in Cell & Developmental Biology, vol. 40, pp. 82-88, 2015.
253. S. E. Haynesworth, M. A. Baber, and A. I. Caplan, "Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1, " Journal of Cellular Physiology, vol. 166, no. 3, pp. 585-592, 1996.
254. B. Yu, X. Zhang, and X. Li, "Exosomes derived from mesenchymal stem cells, " International Journal of Molecular Sciences, vol. 15, no. 3, pp. 4142-4157, 2014.
255. J. R. Lavoie and M. Rosu-Myles, "Uncovering the secretes of mesenchymal stem cells, " Biochimie, vol. 95, no. 12, pp. 2212-2221, 2013.
256. K. C. Vallabhaneni, P. Penfornis, S. Dhule et al., "Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites, " Oncotarget, vol. 6, no. 7, pp. 4953-4967, 2015.
257. T. Kinnaird, E. Stabile, M. S. Burnett et al., "Marrow-derived stromal cells express genes encoding a broad spectrumof arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms, " Circulation Research, vol. 94, no. 5, pp. 678-685, 2004.
258. M. Gnecchi, H. He, N. Noiseux et al., "Evidence supporting paracrine hypothesis for Akt-modifiedmesenchymal stem cellmediated cardiac protection and functional improvement, " The FASEB Journal, vol. 20, no. 6, pp. 661-669, 2006.
259. A. Shabbir, A. Coz, L. Rodriguez, M. Salgado, and E. Badiavas, "Mesenchymal stem cell exosomes induce the proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro, " Stem Cells and Development, 2015.
260. Y. Zhang, M. Chopp, Y. Meng et al., "Effect of exosomes derived frommultipluripotentmesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury, " Journal of Neurosurgery, vol. 122, no. 4, pp. 856-867, 2015.
261. Y.-G. Zhu, X.-M. Feng, J. Abbott et al., "Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice, " Stem Cells, vol. 32, no. 1, pp. 116-125, 2014.
262. K. Deng, D. L. Lin, B. Hanzlicek et al., "Mesenchymal stem cells and their secretome partially restore nerve and urethral function in a dual muscle and nerve injury stress urinary incontinence model, "The American Journal of Physiology: Renal Physiology, vol. 308, no. 2, pp. F92-F100, 2015.
263. M. Ono, N. Kosaka, N. Tominaga et al., "Exosomes frombone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells, " Science Signaling, vol. 7, no. 332, 2014.
264. J.-K. Lee, S.-R. Park, B.-K. Jung et al., "Exosomes derived from mesenchymal stem cells suppress angiogenesis by downregulating VEGF expression in breast cancer cells, " PLoS ONE, vol. 8, no. 12, Article ID e84256, 2013.